This site has just undergone scheduled maintenance in order to be moved to a new infrastructure. You shouldn’t experience any change, but do let us know (datacentre@scilifelab.se) if you think anything looks out of place.

Cerullo V

JSON

CSV

XLSX

TXT

Family name	Cerullo
Given name	Vincenzo
Initials	V
ORCID	ORCID 0000-0003-4901-3796
Affiliations	Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, 00790 Helsinki, Finland. Helsinki Institute of Life Science (HiLIFE), University of Helsinki, 00790 Helsinki, Finland. Translational Immunology Research Program (TRIMM), University of Helsinki, 00790 Helsinki, Finland. iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki, 00790 Helsinki, Finland.

3 publications

PubMed DOI Crossref

Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors.

Chiaro J, Antignani G, Feola S, ..., Lehtiö J, Cerullo V

Nat Commun 14 (1) 7056 [2023-11-03; online 2023-11-03]

Global Proteomics and Proteogenomics [Technology development]

PubMed DOI Crossref

A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines.

Feola S, Chiaro J, Martins B, ..., Lehtiö J, Cerullo V

Elife 11 (-) - [2022-03-22; online 2022-03-22]

Global Proteomics and Proteogenomics [Technology development]

PubMed DOI Crossref

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy.

Peltonen K, Feola S, Umer HM, ..., Lehtiö J, Cerullo V

Cancers (Basel) 13 (14) - [2021-07-07; online 2021-07-07]

Global Proteomics and Proteogenomics [Technology development]